Evidence map›Paper›PMID 29599125›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Establishment of human pluripotent stem cell-derived pancreatic β-like cells in the mouse pancreas.

Haiting Ma, Katherine J Wert, Dmitry Shvartsman, Douglas A Melton, Rudolf Jaenisch

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. From Cells to Organs: The Present and Future of Regenerative Medicine.Advances in experimental medicine and biology · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Haiting MaWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
Katherine J WertWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
Dmitry ShvartsmanDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
Douglas A MeltonDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
Rudolf JaenischWhitehead Institute for Biomedical Research, Cambridge, MA 02142; jaenisch@wi.mit.edu.
Whitehead Institute for Biomedical Research · USHarvard Stem Cell Institute · USHarvard University · US

Funding

In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like CellsR37HD045022 · NICHD · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF · 2009 to 2017
$7.5M
Transcriptional condensates, epigenetic editing and Rett SyndromeR01MH104610 · NIMH · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF, YOUNG, RICHARD · 2014 to 2023
$7.4M
An iPSC based platform for functionally assessing genetic and environmental riskR01NS088538 · NINDS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF, MYERS, RICHARD H · 2014 to 2018
$5.0M
Mechanism and function of autosomal analog of X inactivationR01GM114864 · NIGMS · DANA-FARBER CANCER INST · PI GIMELBRANT, ALEXANDER · 2014 to 2018
$4.9M
Programming and Reprogramming Human CellsR01CA084198 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF · 2009 to 2013
$4.3M
Alzheimer's Disease Risk Genes in Human Microglia and Neurons Derived from iPSCsRF1AG048029 · NIA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI TSAI, LI-HUEI · 2014 to 2014
$2.1M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA084198NIA NIH HHS RF1 AG048029NICHD NIH HHS R37 HD045022NIGMS NIH HHS R01 GM114864NIMH NIH HHS R01 MH104610NINDS NIH HHS R01 NS088538
6 · The paper itself

Abstract

Type 1 diabetes is characterized by autoimmune destruction of β cells located in pancreatic islets. However, tractable in vivo models of human pancreatic β cells have been limited. Here, we generated xenogeneic human pancreatic β-like cells in the mouse pancreas by orthotopic transplantation of stem cell-derived β (SC-β) cells into the pancreas of neonatal mice. The engrafted β-like cells expressed β cell transcription factors and markers associated with functional maturity. Engrafted human cells recruited mouse endothelial cells, suggesting functional integration. Human insulin was detected in the blood circulation of transplanted mice for months after transplantation and increased upon glucose stimulation. In addition to β-like cells, human cells expressing markers for other endocrine pancreas cell types, acinar cells, and pancreatic ductal cells were identified in the pancreata of transplanted mice, indicating that this approach allows studying other human pancreatic cell types in the mouse pancreas. Our results demonstrate that orthotopic transplantation of human SC-β cells into neonatal mice is an experimental platform that allows the generation of mice with human pancreatic β-like cells in the endogenous niche.

Indexed as

Acinar CellsAnimalsCell- and Tissue-Based TherapyCell DifferentiationCell ProliferationCells, CulturedDiabetes Mellitus, Type 1GlucoseHumansInsulinInsulin-Secreting CellsInsulin SecretionMicePancreasPluripotent Stem CellsGlucoseInsulinbeta cellsdiabeteshumanized micehuman pluripotent stem cells

Identifiers

PMID29599125
PMCPMC5899428
OpenAlexW2794778097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.